Figure 3
From: Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
Nomogram for predicting 2-, 5- and 8-year recurrence free survival (RFS) and overall survival (OS) in patients with ccRCC.
(A) Nomogram for predicting RFS integrating pT stage, Fuhrman nuclear grade, necrosis, ECOG PS and tumoral dectin-1 expression; (B–D) Calibration plot for predicted and observed 2-, 5- and 8-year RFS rate; (E) Nomogram for predicting OS integrating pT stage, distant metastasis, Fuhrman nuclear grade, necrosis, ECOG PS and tumoral dectin-1 expression; (F–H) Calibration plot for predicted and observed 2-, 5- and 8-year OS rate. The grey line: ideal model, vertical bars: 95% confident interval.
